Table 4.
Groups | ALP | AST | ALT | CRP |
---|---|---|---|---|
Group I | 150.7 ± 0.013 | 59.41 ± 0.177 | 68.55 ± 0.245 | 105.5 ± 0.186 |
Group II | 271.8 ± 1.379 | 115.2 ± 0.109 | 99.22 ± 0.074 | 135.6 ± 0.141 |
Group III | 149.4 ± 0.471 b* | 70.42 ± 0.199 b* | 80.62 ± 0.158 b* | 110.3 ± 0.297 b* |
Group IV | 199.9 ± 0.886b* | 94.44 ± 2.057b* | 88.22 ± 0.142b* | 122.3 ± 0.142 b* |
Group V | 187.7 ± 0.409b* | 82.19 ± 0.193b* | 84.00 ± 0.258b* | 112.3 ± 0.209 b* |
Group VI | 202.1 ± 0.828b* | 111.7 ± 0.557b* | 99.89 ± 0.432b* | 128.3 ± 0.329 b* |
Group VII | 182.7 ± 0.330b* | 98.77 ± 0.290b* | 96.88 ± 0.209b* | 125.1 ± 0.188 b* |
ALP: Alkaline phosphatase; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; CRP: C reactive protein.
Group I: Normal control; Group II: Negative control; Group III: Positive control; Group IV: ESBCI (28 days drug treatment); Group V: ESCI (28 days drug treatment); Group VI: ESBCI (14 days drug treatment); Group VII: ESCI (14 days drug treatment).
Values are expressed as mean ± SEM, n = 6 animals in each group.
Comparisons were made between: b: Group II vs. groups III, IV, V, VI and VII. c: Group III vs. groups IV, V, VI and VII.
Represents the statistical significance at p < .05.